SPY736.53+0.17%QQQ657.50+0.21%BTC/USD74,000.38−0.97%DIA512.52+0.06%GLD373.37+0.23%TLT81.85−0.09%

Premium Services

Insight Molecular Diagnostics Inc

IMDXNASDAQ

Trade with Public

Trade with Public

$2.49

0.031.22%

Last update: Nov 5, 4:00 PM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Insight Molecular (IMDX) Stock Price Target 2026

The average analyst price target for Insight Molecular is $9.67, 299.6% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $8 to $12. The latest change came on Aug 24, 2026, when LUCID CAPITAL MARKETS initiated coverage of Insight Molecular with a Buy rating and a $8 price target.

The Average Analyst Price Target for Insight Molecular is $9.67.

Price Target Range — 4 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingBuy# Analysts3Avg. Consensus PT$9.67Upside to Avg. PT+299.6%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Insight Molecular Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 24, 2026	LUCID CAPITAL MARKETS	Alex Nowark	Initiate	Buy	$8
Aug 18, 2026	Needham	Mike Matson	Maintained	Buy	$9
Feb 17, 2026	Lake Street	Thomas Flaten	PT Raise	Buy	$8→$12
Nov 11, 2025	Needham	Mike Matson	PT Raise	Buy	$4→$9
Aug 18, 2025	Needham	Mike Matson	Maintained	Buy	$4

Analyst Ratings News

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Insight Molecular with Buy Rating, Announces Price Target of $8

LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Insight Molecular (NASDAQ:IMDX) with a Buy rating and announces Price Target of $8.

Benzinga Newsdesk

PRO
Needham Reiterates Buy on Insight Molecular, Maintains $9 Price Target

Needham analyst Mike Matson reiterates Insight Molecular (NASDAQ:IMDX) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Insight Molecular, Raises Price Target to $12

Lake Street analyst Thomas Flaten maintains Insight Molecular (NASDAQ:IMDX) with a Buy and raises the price target from $8 to $12.

Benzinga Newsdesk

PRO
Needham Maintains Buy on Insight Molecular, Raises Price Target to $9

Needham analyst Mike Matson maintains Insight Molecular (NASDAQ:IMDX) with a Buy and raises the price target from $4.25 to $9.

Benzinga Newsdesk

PRO
Needham Reiterates Buy on Insight Molecular, Maintains $4.25 Price Target

Needham analyst Mike Matson reiterates Insight Molecular (NASDAQ:IMDX) with a Buy and maintains $4.25 price target.

Benzinga Newsdesk